Effect of radioprotective agents on X-ray cataracts

ORCiD

0000-0001-9010-5970

Document Type

Article

Publication Title

Lens and Eye Toxicity Research

ISSN

1042-6922

Volume

6

Issue

4

DOI

https://www.ncbi.nlm.nih.gov/pubmed/2562120/

First Page

573

Last Page

588

Publication Date

1-1-1989

Abstract

The effect of some protective agents on cataract development is briefly reviewed and new evidence is presented on the efficacy of a phosphorothioate compound (Amifostine) in inhibiting the development of X-ray-induced cataract. Morphological studies showed that at the end of 4 months, lenses from X-irradiated rats which had not received any drugs showed liquefaction in the equatorial region and at the posterior pole, as well as a marked swelling of the fibers in the anterior cortex. Animals which received 1.16g/kg of WR77913 showed considerable protection against the development of radiation induced cataracts with morphological changes in the lens being less severe than in animals receiving no drugs. When animals were treated with 0.5g/kg of Amifostine (WR2721) the lenses showed much greater protection against cataract development than with WR77913. Amifostine appears to be more effective than WR77913 in inhibiting X-ray-induced cataract development.

Link to Full Text

Share

COinS